Our findings demonstrate numerous clinical opportunities for germline PGx and DDI management in adults with advanced cancer.
No takes yet. Share an insight, caveat, or question.
Shugg et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: